Skip to main content

Advertisement

Log in

Prognostic Value of Lymph Node Density Compared to Pre-operative Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients with Tongue Squamous Cell Carcinoma

  • Original Article
  • Published:
Journal of Maxillofacial and Oral Surgery Aims and scope Submit manuscript

Abstract

Background

We aimed to investigate the prognostic significance of lymph node density (LND), and pre-operative neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for outcome measuring in tongue squamous cell carcinoma (TSCC)’ patients.

Methods

A total of 129 patients who underwent surgery for TSCC were enrolled in this retrospective study. LND and pre-operative NLR and PLR were used as outcome measures and their correlations with different clinicopathological features were examined.

Results

The cutoff values for NLR, PLR, and LND were obtained 1.21, 97.81, and 0.02, respectively, by receiver operating characteristic (ROC) curve approach. Only LND was found to be significantly associated with decreased overall survival (HR = 4.24; 95% CI 1.49–12.10; P = 0.007) and disease-free survival (HR = 3.48; 95% CI 1.43–8.45; P = 0.006) both in univariate and multivariate analyzes.

Conclusion

Based on the findings, the LND has superiority over pre-operative NLR and PLR in predicting outcomes for the patients with TSCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Feller L, Lemmer J (2012) Oral squamous cell carcinoma: epidemiology, clinical presentation and treatment. J Cancer Ther 3(04):263

    Article  Google Scholar 

  2. Palve DH, Tupkari JV (2008) Clinico-pathological correlation of micronuclei in oral squamous cell carcinoma by exfoliative cytology. J Oral MaxillofacPathol 12(1):2

    Google Scholar 

  3. Bachar G, Hod R, Goldstein D, Irish J, Gullane P, Brown D et al (2011) Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors. Oral Oncol 47(1):45–50

    Article  CAS  PubMed  Google Scholar 

  4. Veness MJ, Morgan GJ, Sathiyaseelan Y, Gebski V (2005) Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ J Surg 75(3):101–105

    Article  PubMed  Google Scholar 

  5. Ganly I, Goldstein D, Carlson DL, Patel SG, O’Sullivan B, Lee N et al (2013) Long-term regional control and survival in patients with “low-risk”, early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness. Cancer 119(6):1168–1176

    Article  PubMed  Google Scholar 

  6. Zhang L, Zhou X, Yao X, Wu Y, Zhang Q, Zhang L (2012) Oral tongue cancer patients show a better overall survival than base of tongue cancer patients. J Cancer Res ClinOncol 138(2):341–346

    Article  Google Scholar 

  7. Tsai YD, Wang CP, Chen CY, Lin LW, Hwang TZ, Lu LF et al (2014) Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 36(7):947–953

    Article  PubMed  Google Scholar 

  8. Piccard H, Muschel R, Opdenakker G (2012) On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev OncolHematol 82(3):296–309

    Article  CAS  Google Scholar 

  9. Zhou C, Liu J, Tang Y, Liang X (2012) Inflammation linking EMT and cancer stem cells. Oral Oncol 48(11):1068–1075

    Article  CAS  PubMed  Google Scholar 

  10. Chua W, Charles K, Baracos V, Clarke S (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104(8):1288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M et al (2016) Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann SurgOncol 23(2):646–654

    Google Scholar 

  12. Wei X, Wang F, Zhang D, Qiu M, Ren C, Jin Y et al (2015) A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer 15(1):350

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K et al (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103(9):1856–1864

    Article  CAS  PubMed  Google Scholar 

  14. Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann SurgOncol 19(1):217–224

    Google Scholar 

  15. Krenn-Pilko S, Langsenlehner U, Thurner E, Stojakovic T, Pichler M, Gerger A et al (2014) The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 110(10):2524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kitano Y, Yamashita Y-I, Yamamura K, Arima K, Kaida T, Miyata T et al (2017) Effects of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios on survival in patients with extrahepaticcholangiocarcinoma. Anticancer Res 37(6):3229–3237

    CAS  PubMed  Google Scholar 

  17. Chen S, Guo J, Feng C, Ke Z, Chen L, Pan Y (2016) The preoperative platelet–lymphocyte ratio versus neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? TherAdv Med Oncol 8(3):160–167

    Article  Google Scholar 

  18. Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K et al (2009) Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Int J Urol 16(3):274–278

    Article  PubMed  Google Scholar 

  19. Patel S, Amit M, Yen T, Liao C, Chaturvedi P, Agarwal J et al (2013) Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br J Cancer 109(8):2087

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 18(7):40

    Article  PubMed  Google Scholar 

  21. Amit M, Tam S, Takahashi H, Choi KY, Zafereo M, Bell D et al (2019) Prognostic performance of the American Joint Committee on Cancer 8th edition of the TNM staging system in patients with early oral tongue cancer. Head Neck 41(5):1270–1276

    Article  PubMed  Google Scholar 

  22. Sun W, Zhang L, Luo M, Hu G, Mei Q, Liu D et al (2016) Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Head Neck 38(S1):E1332–E1340

    Article  PubMed  Google Scholar 

  23. Ma X, Wang Y, Sheng H, Tian W, Qi Z, Teng F et al (2014) Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer. J ObstetrGynaecol Res 40(1):178–183

    Google Scholar 

  24. Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D et al (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21(8):938–945

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Wu L, Saxena S, Awaji M, Singh RK (2019) Tumor-associated neutrophils in cancer: going pro. Cancers 11(4):564

    Article  CAS  PubMed Central  Google Scholar 

  26. Gargiulo P, Dietrich D, Herrmann R, Bodoky G, Ruhstaller T, Scheithauer W et al (2019) Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores. TherapAdv Med Oncol 11:1758835918818351

    CAS  Google Scholar 

  27. Ozturk K, Akyildiz NS, Uslu M, Gode S, Uluoz U (2016) The effect of preoperative neutrophil, platelet and lymphocyte counts on local recurrence and survival in early-stage tongue cancer. Eur Arch Otorhinolaryngol 273(12):4425–4429

    Article  PubMed  Google Scholar 

  28. Ong HS, Gokavarapu S, Wang LZ, Tian Z, Zhang CP (2017) Low pretreatment lymphocyte–monocyte ratio and high platelet-lymphocyte ratio indicate poor cancer outcome in early tongue cancer. J Oral MaxillofacSurg 75(8):1762–1774

    Article  Google Scholar 

  29. Grimm M, Rieth J, Hoefert S, Krimmel M, Rieth S, Teriete P et al (2016) Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma. Eur Arch Otorhinolaryngol 273(10):3371–3384

    Article  PubMed  Google Scholar 

  30. Acharya S, Rai P, Hallikeri K, Anehosur V, Kale J (2017) Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma. Journal of investigative and clinical dentistry 8(3):e12219

    Article  Google Scholar 

  31. Sano Y, Kogashiwa Y, Araki R, Enoki Y, Ikeda T, Yoda T et al (2018) Correlation of inflammatory markers, survival, and COX2 expression in oral cancer and implications for prognosis. Otolaryngology-Head and Neck Surgery 158(4):667–676

    Article  PubMed  Google Scholar 

  32. Zhang Y, Zheng L, Quan L, Du L. Prognostic role of platelet‐to‐lymphocyte ratio in oral cancer: A meta‐analysis. Journal of Oral Pathology & Medicine. 2019.

  33. Yu W, Dou Y, Wang K, Liu Y, Sun J, Gao H et al (2019) Preoperative neutrophil lymphocyte ratio but not platelet lymphocyte ratio predicts survival and early relapse in patients with oral, pharyngeal, and lip cancer. Head Neck 41(5):1468–1474

    Article  PubMed  Google Scholar 

  34. Bharath V, Balagopal P, Nebu A, Jayasudha A, Iqbal MA, Sebastian P (2018) Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue? The Gulf journal of oncology 1(28):6–10

    CAS  PubMed  Google Scholar 

  35. Lieng H, Gebski VJ, Morgan GJ, Veness MJ (2016) Important prognostic significance of lymph node density in patients with node positive oral tongue cancer. ANZ J Surg 86(9):681–686

    Article  PubMed  Google Scholar 

  36. Kim K-Y, Cha I-H (2012) Risk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarker. J Cancer Res ClinOncol 138(3):483–490

    Article  Google Scholar 

  37. Kim SY, Nam SY, Choi S-H, Cho K-J, Roh J-L (2011) Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma. Ann SurgOncol 18(8):2310–2317

    Google Scholar 

  38. Suzuki H, Hanai N, Hirakawa H, Nishikawa D, Hasegawa Y (2015) Lymph node density is a prognostic factor in patients with major salivary gland carcinoma. Oncology letters 10(6):3523–3528

    Article  PubMed  PubMed Central  Google Scholar 

  39. Martin TA, Ye L, Sanders AJ, Lane J, Jiang WG. Cancer invasion and metastasis: molecular and cellular perspective. Madame Curie Bioscience Database [Internet]. Landes Bioscience; 2013.

  40. Jones D, Pereira ER, Padera TP (2018) Growth and immune evasion of lymph node metastasis. Frontiers in oncology 8:36

    Article  PubMed  PubMed Central  Google Scholar 

  41. Wang Q, Zhu D (2019) The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer. Journal of gastrointestinal oncology 10(5):965

    Article  PubMed  PubMed Central  Google Scholar 

  42. Li C, Tian W, Zhao F, Li M, Ye Q, Wei Y et al (2018) Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors. Oncotarget 9(82):35293

    Article  PubMed  PubMed Central  Google Scholar 

  43. Diao P, Wu Y, Li J, Zhang W, Huang R, Zhou C et al (2018) Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. J Transl Med 16(1):365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was carried out at Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran and financially was supported by Tehran University of Medical Sciences, Tehran, Iran [Grant NO# 97-02-51-39760]. The authors would like to give special thanks to the all staffs of Cancer Institute and Medical University of Tehran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amirmohsen Jalaeefar.

Ethics declarations

Conflict of interest

The authors declare that they have no financial or commercial conflicts of interest and are responsible for the content and writing of this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khazravi, M., Shirkhoda, M., Saffar, H. et al. Prognostic Value of Lymph Node Density Compared to Pre-operative Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients with Tongue Squamous Cell Carcinoma. J. Maxillofac. Oral Surg. 21, 845–855 (2022). https://doi.org/10.1007/s12663-021-01524-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12663-021-01524-1

Keywords

Navigation